Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...

In 2024, drug makers lowered the cost of dozens of common medications to avoid penalties imposed by the American Rescue Plan, Katie Thomas of ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

Gov. Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

In a report released today, Florent Cespedes from Bernstein maintained a Hold rating on Novo Nordisk (0QIU – Research Report), with a price ...

Testing has shown reduced bioavailability due to impurities and fibril formation, rendering these products less effective or ...

Novo Nordisk is doubling down on its collaboration with Valo Health, committing up to $190 million in near-term payments—and ...

The lawsuit said an “unfair and deceptive conspiracy” by drug makers and drug distributors fixed prices for Georgians.

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...